Skip to content
Disclosery

EXANE DERIVATIVES: BMY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BMY, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 17,094 BMY shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 17,094 shares
    Change vs previous 13F +6,261 shares

    0.76% of the 13F portfolio, value $1,315,948.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 10,833 shares
    Change vs previous 13F -11,351 shares

    0.22% of the 13F portfolio, value $791,074.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 22,184 shares
    Change vs previous 13F +4,175 shares

    0.34% of the 13F portfolio, value $1,383,103.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 18,009 shares
    Change vs previous 13F +470 shares

    0.27% of the 13F portfolio, value $1,065,540.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 17,539 shares
    Change vs previous 13F -1,165 shares

    0.28% of the 13F portfolio, value $1,182,793.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 18,704 shares
    Change vs previous 13F -307 shares

    0.36% of the 13F portfolio, value $1,180,712.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 19,011 shares
    Change vs previous 13F -17,572 shares

    0.36% of the 13F portfolio, value $1,179,178.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 36,583 shares
    Change vs previous 13F not available

    0.72% of the 13F portfolio, value $2,205,497.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).